BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
1092 results:

  • 1. Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
    Popov A; Henze G; Tsaur G; Budanov O; Roumiantseva J; Belevtsev M; Verzhbitskaya T; Movchan L; Lagoyko S; Zharikova L; Olshanskaya Y; Riger T; Valochnik A; Miakova N; Litvinov D; Khlebnikova O; Streneva O; Stolyarova E; Ponomareva N; Novichkova G; Aleinikova O; Fechina L; Karachunskiy A
    Cancer Med; 2024 Apr; 13(8):e7172. PubMed ID: 38651186
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
    Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Use of the ETV6/runx1 probe to verify the performance of the fluorescence in situ hybridization probe before clinical detection].
    Xiao J; Zheng YC; Zhao JW; Cui CH; Wang HJ; Sun Q; Ma J; Ma YS; Song Z; Xiao ZJ; Li CW
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):48-53. PubMed ID: 38527838
    [No Abstract]    [Full Text] [Related]  

  • 4. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 5. Epidemiology and risk factors of bloodstream infections among adolescents and young adults with acute lymphoblastic leukaemia: An 11-year retrospective cohort study.
    Xue L; Tang Y; Wang L; Xu C; Cheng Q; Li X
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13850. PubMed ID: 38452755
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.
    Kubota Y; Gu X; Terkawi L; Bodo J; Przychodzen BP; Awada H; Williams N; Gurnari C; Kawashima N; Aly M; Durmaz A; Mori M; Ponvilawan B; Kewan T; Bahaj W; Meggendorfer M; Jha BK; Visconte V; Rogers HJ; Haferlach T; Maciejewski JP
    Nat Commun; 2024 Feb; 15(1):1832. PubMed ID: 38418452
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
    Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
    [No Abstract]    [Full Text] [Related]  

  • 8. Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review.
    Lobo-Alves SC; Oliveira LA; Kretzschmar GC; Valengo AE; Rosati R
    Crit Rev Oncol Hematol; 2024 Apr; 196():104290. PubMed ID: 38341118
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
    Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
    Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells.
    Kreissig S; Windisch R; Wichmann C
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201282
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing runx1 transcription.
    Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
    Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
    Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
    Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synchronous presentation of
    Khera S; Kurup A; Agarwal S; Tripathi P
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967932
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia.
    Aoki K; Hyuga M; Tarumoto Y; Nishibuchi G; Ueda A; Ochi Y; Sugino S; Mikami T; Kobushi H; Kato I; Akahane K; Inukai T; Takaori-Kondo A; Takita J; Ogawa S; Yusa K
    Blood; 2024 Feb; 143(7):604-618. PubMed ID: 37922452
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive genomic profiling reveals molecular subsets of
    Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
    Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
    Williams LS; Williams KM; Gillis N; Bolton K; Damm F; Deuitch NT; Farhadfar N; Gergis U; Keel SB; Michelis FV; Panch SR; Porter CC; Sucheston-Campbell L; Tamari R; Stefanski HE; Godley LA; Lai C
    Transplant Cell Ther; 2024 Mar; 30(3):255-267. PubMed ID: 37913908
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. runx1 rearrangement in mature B-cell acute lymphoblastic leukemia with non-L3 morphology.
    Yamamoto K; Kitao A; Watanabe M; Kanehira H; Joyce M; Hirakawa Y; Matsumoto S; Yakushijin K; Minami H
    J Clin Exp Hematop; 2023 Dec; 63(4):240-245. PubMed ID: 37899239
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 55.